NCT03411226 (re-TREPP) is a clinical trial of re-TREPP in Recurrent Inguinal Hernia, sponsored by Alexandra Persoon.

Who is sponsoring NCT03411226?

NCT03411226 is sponsored by Alexandra Persoon.

What drugs are being tested in NCT03411226?

Interventions in NCT03411226: re-TREPP.

What condition does NCT03411226 study?

NCT03411226 studies Recurrent Inguinal Hernia.

Is NCT03411226 still recruiting?

NCT03411226 is currently completed. Last updated 29 January 2018.

Last reviewed 2018-01-29 · How we verify

NCT03411226: re-TREPP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of Re-TREPP in Patients With a Recurrent Inguinal Hernia After Previous TREPP Repair

Completed Last updated 29 January 2018

What this trial tests

trial testing re-TREPP in Recurrent Inguinal Hernia in 19 participants. Completed in 31 January 2016.

Timeline

27 November 2015

Primary endpoint
10 December 2015

31 January 2016

Quick facts

Lead sponsor	Alexandra Persoon
Status	Completed
Study type	OBSERVATIONAL
Enrollment	19
Start date	27 November 2015
Primary completion	10 December 2015
Estimated completion	31 January 2016

Drugs / interventions tested

re-TREPP

Conditions studied

Recurrent Inguinal Hernia — all drugs for Recurrent Inguinal Hernia →

Sponsor

Alexandra Persoon

Who can join

18 and older, any sex, with Recurrent Inguinal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Trans REctussheath PrePeritoneal (TREPP) mesh repair was introduced in 2006 to decrease the risk of postoperative inguinal pain in hernia surgery. For the repair of a recurrent inguinal hernia after a primary TREPP an alternative open anterior route (Lichtenstein) may seem the most logical option, but coincides with an increased risk of chronic postoperative inguinal pain. Therefore, this study aimed to evaluate the feasibility of a second TREPP procedure to repair a recurrent inguinal hernia after an initial TREPP repair. The hypothesis was that the technique is possible and does not lead to an increased risk of postoperative pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Recurrent Inguinal Hernia

Currently open trials in the same condition.

NCT06604572 — TAPP and Open Repair for Recurrent Inguinal Hernia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03411226 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alexandra Persoon
Last refreshed: 29 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03411226.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing